Skip to content
Search

Latest Stories

GPhC updates guidance for pharmacies providing services online

The General Pharmaceutical Council (GPhC) has updated its guidance for registered pharmacy providing pharmacy service at a distance, including internet.

The guidance explains what pharmacy owners should consider before deciding whether any parts of their pharmacy service can be provided safely and effectively at a distance (including on the internet), rather than in the traditional face-to-face way.


Updates to the guidance, which was originally published in 2019, include:

  • providing additional examples, such as the types of collection and delivery services
  • further clarity around identity-checking of people using the service
  • aligning the guidance with prescribing guidance
  • updates following guidance produced by others, including the GMC

The Council said: “We are writing to pharmacy owners to ask them to review the updated guidance and make sure it is followed within their pharmacy. Everyone in the pharmacy team, including managers with delegated responsibility and the responsible pharmacist, should understand the guidance and be aware of their responsibilities to follow it.

“The guidance should be used alongside the standards for registered pharmacies, our inspection decision making framework and the standards for pharmacy professionals and its supporting guidance.”

During the interim review of the guidance, some stakeholders questioned why it was necessary for pharmacy websites to be ‘arranged so that a person cannot choose a prescription-only medicine (POM) and its quantity before there has been an appropriate consultation with a prescriber.’

The GPhC Council discussed this issue at its December meeting and agreed that this requirement provided an important safeguard for patients and the public using online services, and that it should remain in place. However, to provide clarity, the words ‘and its quantity’ have been removed in the updated version of the guidance.

The Council heard that its inspectors have observed the relative immaturity of operating models and prescribing practice in online pharmacies when compared to other types of providers, as well as under-developed clinical governance structures.

During inspections, inspectors identified examples of pharmacy governance models without the appropriate monitoring, after-care and safeguarding, and have taken appropriate action in response to protect patient safety.

In August 2021, the Council wrote to pharmacy organisations to highlight the serious patient safety concerns the regulator had identified relating to online prescribing services. These concerns include cases relating to registered pharmacies dispensing POMs from prescribers based in the EEA working alone or for third party online prescribing services.

“This is a fast-changing area, and it is important that we respond quickly and effectively to developments. We will continue to consider what further steps we should take to strengthen online pharmacy regulation, to help us to achieve our ten-year vision of safe and effective pharmacy care at the heart of healthier communities,” GPhC concluded.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less